Track open bid opportunities, contracts, public meetings, and key contacts for Arizona State Board of Pharmacy.
Key metrics and characteristics
City
The city where this buyer is located.
Phoenix
County
The county where this buyer is located.
Maricopa
Address
Physical address of this buyer.
1110 W Washington St # 260
Phone Number
Contact phone number for this buyer.
(602) 771-2727
Zip Code
Postal code for this buyer's location.
85005
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Board meetings and strategic plans from Arizona State Board of Pharmacy
The Board conducted a review of several complaint cases involving pharmacy practice, including medication temperature excursions and failure to report criminal charges. Decisions were made regarding a consent agreement for voluntary surrender and multiple dismissals for complaint cases where corrective actions were taken by pharmacies or insufficient evidence of violations was found. The Board also reviewed a case regarding a pharmacist's failure to report a criminal charge and considered the imposition of a non-disciplinary civil penalty.
The meeting commenced with roll call and conflict of interest declarations, followed by an update on the CSPMP workgroup's compliance efforts. The board addressed two informal settlement conferences: one involving Sterling Distributors regarding unpermitted product distribution, for which the board voted to advance to a formal hearing while allowing for continued settlement negotiations; and another regarding Palani Joseph Ray, who requested a payment extension for a fine.
The taskforce discussed proposed changes to compounding rules, including addressing errors in references to adulterated drugs. Key discussion points included the need for clarification on compounding for diagnostic and sensitivity testing, and the challenges faced by health systems in outpatient settings such as ambulatory surgery centers and infusion clinics. The taskforce considered whether these outpatient locations require a specific permit that allows hospital-like pharmacy practices, such as specific labeling and the use of automated dispensing machines, without being restricted by retail pharmacy regulations.
Extracted from official board minutes, strategic plans, and video transcripts.
Track Arizona State Board of Pharmacy meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Public-sector contacts connected to Arizona State Board of Pharmacy.
Quotable insights from buyer leadership
